BBIO icon

BridgeBio Pharma

251 hedge funds and large institutions have $4.36B invested in BridgeBio Pharma in 2024 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 106 increasing their positions, 73 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
251
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
13
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$288M
Puts
$68.9M
Net Calls
Net Calls Change

Top Buyers

1 +$44.5M
2 +$26.5M
3 +$20.4M
4
Citadel Advisors
Citadel Advisors
Florida
+$20M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$12.9M

Top Sellers

1 -$148M
2 -$35.7M
3 -$30.8M
4
PBA
Paradigm Biocapital Advisors
New York
-$27.6M
5
Man Group
Man Group
United Kingdom
-$15.7M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$2.06M
102
$1.99M
103
$1.98M
104
$1.97M
105
$1.95M
106
$1.91M
107
$1.91M
108
$1.85M
109
$1.77M
110
$1.77M
111
$1.76M
112
$1.73M
113
$1.6M
114
$1.6M
115
$1.56M
116
$1.53M
117
$1.49M
118
$1.36M
119
$1.3M
120
$1.3M
121
$1.29M
122
$1.26M
123
$1.25M
124
$1.25M
125
$1.24M